Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | Director | November 20, 2019 | November 22, 2019 |
| HUBBELL INCHUBB · Entity 3208 | Director | May 03, 2018 | May 03, 2018 |
| KAMAN CorpKAMN · Entity 91838 | Director | December 31, 2018 | February 13, 2019 |
| PUBLIC SERVICE ENTERPRISE GROUP INCPEG · Entity 203 | Director | May 01, 2019 | May 02, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date November 20, 2019 · Filed November 22, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,336 |
Reported balance
After 2019-11-20 transaction · row 1
1 source rowRow 1 · 2019-11-20 · Grant · Acquired 1,676 · Balance 7,336 F1: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. |
| Share CreditsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 64,437.8906 |
Reported balance
Holding disclosure · report date 2019-11-20 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 64,437.8906 F2: Consists of deferred stock compensation payable pursuant to Reporting Person's election. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.
F2: Consists of deferred stock compensation payable pursuant to Reporting Person's election.
HUBBELL INC
Report date May 03, 2018 · Filed May 03, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,313 |
Reported balance
After 2018-05-03 transaction · row 1
1 source rowRow 1 · 2018-05-03 · Grant · Acquired 1,172 · Balance 5,313 F1: Restricted stock grant vesting on date of next regularly scheduled Annual Meeting of Shareholders to be held in 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock grant vesting on date of next regularly scheduled Annual Meeting of Shareholders to be held in 2019.
KAMAN Corp
Report date December 31, 2018 · Filed February 13, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Kaman Common StockSEC Table I · non-derivative | Direct | 16,410 |
Reported balance
Holding disclosure · report date 2018-12-31 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 16,410 |
PUBLIC SERVICE ENTERPRISE GROUP INC
Report date May 01, 2019 · Filed May 02, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 47,277.6944 |
Reported balance
After 2019-05-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-05-01 · Grant · Acquired 2,297 · Balance 47,277.6944 F1: Restricted Stock Units convert to common stock on a one-for-one basis. Restricted Stock Units represent the share equivalent of amount granted, with payment deferred, under the Equity Compensation Plan For Directors. F2: Restricted Stock Units are subject to forfeiture if a director leaves service and are paid in shares of common stock after termination of service. F3: The derivative, Restricted Stock Units, do not have a corresponding exercisable date nor expiration date. F4: Amount includes accumulated dividend reinvestment equivalents that are exempt from Section 16. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted Stock Units convert to common stock on a one-for-one basis. Restricted Stock Units represent the share equivalent of amount granted, with payment deferred, under the Equity Compensation Plan For Directors.
F2: Restricted Stock Units are subject to forfeiture if a director leaves service and are paid in shares of common stock after termination of service.
F3: The derivative, Restricted Stock Units, do not have a corresponding exercisable date nor expiration date.
F4: Amount includes accumulated dividend reinvestment equivalents that are exempt from Section 16.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Trane Technologies plc
Report date June 03, 2021 · Filed June 07, 2021
Section 16 reporting ended · disclosed 2021-06-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 87,403.967 |
Reported balance
After 2021-06-03 transaction · row 1
1 source rowRow 1 · 2021-06-03 · Tax withholding · Disposed 654 · Balance 87,403.967 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2021 Filed Jun 7, 2021 20:11 UTC | Trane Technologies plc TT · Entity 2921 | Tax withholdingOrdinary Shares | 654 | $183.36 | $119,917.44 |
DisclosureSEC source: 0001466258-21-000134 · wf-form4_162309669743396.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,403.967 Read SEC document |
| August 27, 2020 Filed Aug 28, 2020 20:02 UTC | Trane Technologies plc TT · Entity 2921 | SaleOrdinary Shares | 4,354 | $120.02 | $522,555.32 |
DisclosureSEC source: 0001466258-20-000206 · wf-form4_159864495174967.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,064.502 F1 · price: This transaction was executed in multiple trades ranging from $120.0085 to $120.0218 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 06, 2020 Filed Jun 9, 2020 20:19 UTC | Trane Technologies plc TT · Entity 2921 | Tax withholdingOrdinary Shares | 802 | $102.01 | $81,812.02 |
DisclosureSEC source: 0001466258-20-000158 · wf-form4_159173393163066.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,912.38 Read SEC document |
| June 04, 2020 Filed Jun 8, 2020 20:24 UTC | Trane Technologies plc TT · Entity 2921 | GrantOrdinary Shares | 1,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001466258-20-000124 · wf-form4_159164784683427.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,714.38 F1 · shares: Represents restricted stock units that fully vest on June 4, 2021. Read SEC document |
| November 20, 2019 Filed Nov 22, 2019 21:29 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 1,676 | $74.92 | $125,565.92 |
DisclosureSEC source: 0001127602-19-033589 · form4.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,336 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 20:11 UTC | Trane Technologies plc IR · Entity 2921 | Tax withholdingOrdinary Shares | 866 | $125.22 | $108,440.52 |
DisclosureSEC source: 0001466258-19-000215 · wf-form4_156028386585785.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,698.8 Read SEC document |
| June 06, 2019 Filed Jun 10, 2019 20:45 UTC | Trane Technologies plc IR · Entity 2921 | GrantOrdinary Shares | 1,301 | $0.00 | $0.00 |
DisclosureSEC source: 0001466258-19-000193 · wf-form4_156019948945962.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,564.8 F1 · shares: Represents restricted stock units that fully vest on June 6, 2020. Read SEC document |
| May 16, 2019 Filed May 20, 2019 21:11 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 2,402 | $52.30 | $125,624.60 |
DisclosureSEC source: 0001127602-19-019172 · form4.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,660 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| May 01, 2019 Filed May 2, 2019 21:11 UTC | PUBLIC SERVICE ENTERPRISE GROUP INC PEG · Entity 203 | GrantRestricted Stock Units · Derivative | 2,297 | $58.78 | $135,017.66 |
DisclosureSEC source: 0001225208-19-007607 · doc4.xml · derivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,277.6944 Underlying: Common Stock · 2,297 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units convert to common stock on a one-for-one basis. Restricted Stock Units represent the share equivalent of amount granted, with payment deferred, under the Equity Compensation Plan For Directors. F2 · kind: Restricted Stock Units are subject to forfeiture if a director leaves service and are paid in shares of common stock after termination of service. F3 · derivative.exercise_date: The derivative, Restricted Stock Units, do not have a corresponding exercisable date nor expiration date. F3 · derivative.expiration_date: The derivative, Restricted Stock Units, do not have a corresponding exercisable date nor expiration date. F4 · balance_after: Amount includes accumulated dividend reinvestment equivalents that are exempt from Section 16. Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 21:50 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,452.0122 | $78.77 Strike: $0.00 | $114,375.00 |
DisclosureSEC source: 0001127602-18-032666 · form4.xml · derivative · entry 2 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,371.0817 Underlying: Common Stock · 1,452.0122 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| June 08, 2018 Filed Jun 12, 2018 20:09 UTC | Trane Technologies plc IR · Entity 2921 | Tax withholdingOrdinary Shares | 778 | $90.51 | $70,412.89 |
DisclosureSEC source: 0001466258-18-000179 · wf-form4_152883414259206.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,923.76 Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 20:08 UTC | Trane Technologies plc IR · Entity 2921 | GrantOrdinary Shares | 1,804 | $0.00 | $0.00 |
DisclosureSEC source: 0001466258-18-000156 · wf-form4_152874770713396.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,701.76 F1 · shares: Represents restricted stock units that fully vest on June 7, 2019. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 20:16 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,784.3214 | $64.10 Strike: $0.00 | $114,375.00 |
DisclosureSEC source: 0001127602-18-020150 · form4.xml · derivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,044.0189 Underlying: Common Stock · 1,784.3214 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 30, 2018 Filed May 31, 2018 16:15 UTC | KAMAN Corp KAMN · Entity 91838 | SaleKaman Common Stock | 2,500 | $72.00 | $180,000.00 |
DisclosureSEC source: 0001127602-18-019324 · form4.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,410 F1 · shares: This is a sale of shares on 5/30/2018 at $72.00 a share. The reporting person will provide full information regarding the shares sold upon request by the SEC staff, the issuer, or any security holder of the issuer. Read SEC document |
| May 03, 2018 Filed May 3, 2018 21:12 UTC | HUBBELL INC HUBB · Entity 3208 | GrantCommon Stock | 1,172 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-18-005880 · wf-form4_152538189427380.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,313 F1 · price: Restricted stock grant vesting on date of next regularly scheduled Annual Meeting of Shareholders to be held in 2019. Read SEC document |
| May 01, 2018 Filed May 2, 2018 18:59 UTC | PUBLIC SERVICE ENTERPRISE GROUP INC PEG · Entity 203 | GrantRestricted Stock Units · Derivative | 2,604 | $51.86 | $135,043.44 |
DisclosureSEC source: 0001225208-18-008493 · doc4.xml · derivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,509.4455 Underlying: Common Stock · 2,604 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units convert to common stock on a one-for-one basis. Restricted Stock Units represent the share equivalent of amount granted, with payment deferred, under the Equity Compensation Plan For Directors. F2 · kind: Restricted Stock Units are subject to forfeiture if a director leaves service and are paid in shares of common stock after termination of service. F3 · derivative.exercise_date: The derivative, Restricted Stock Units, do not have a corresponding exercisable date nor expiration date. F3 · derivative.expiration_date: The derivative, Restricted Stock Units, do not have a corresponding exercisable date nor expiration date. F4 · balance_after: Amount includes accumulated dividend reinvestment equivalents that are exempt from Section 16. Read SEC document |
| April 18, 2018 Filed Apr 18, 2018 16:40 UTC | KAMAN Corp KAMN · Entity 91838 | GrantKaman Common Stock | 1,973 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-014868 · form4.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,910 F1 · shares: Represents an unrestricted equity award under the Corporation's 16b-3 qualified 2013 Management Incentive Plan. Read SEC document |
| November 16, 2017 Filed Nov 17, 2017 16:04 UTC | KAMAN Corp KAMN · Entity 91838 | SaleKaman Common Stock | 1,765 | $55.97 | $98,782.11 |
DisclosureSEC source: 0001127602-17-032609 · form4.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,937 F1 · price: This figure represents the weighted average sale price for the shares sold. The range of prices was $55.96 to $55.99. The reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer, or any security holder of the issuer. Read SEC document |
| November 15, 2017 Filed Nov 16, 2017 14:02 UTC | KAMAN Corp KAMN · Entity 91838 | SaleKaman Common Stock | 1,235 | $56.00 | $69,157.04 |
DisclosureSEC source: 0001127602-17-032368 · form4.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,702 F1 · price: This figure represents the weighted average sale price for the shares sold. The range of prices was $55.96 to $56.06. The reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer, or any security holder of the issuer. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:45 UTC | HUBBELL INC HUBB · Entity 3208 | SaleCommon Stock | 1,061 | $120.60 | $127,957.66 |
DisclosureSEC source: 0001628280-17-011677 · wf-form4_151095513198824.xml · nonDerivative · entry 4 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,141 Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:45 UTC | HUBBELL INC HUBB · Entity 3208 | SaleCommon Stock | 739 | $120.51 | $89,058.15 |
DisclosureSEC source: 0001628280-17-011677 · wf-form4_151095513198824.xml · nonDerivative · entry 3 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,202 Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:45 UTC | HUBBELL INC HUBB · Entity 3208 | SaleCommon Stock | 100 | $120.55 | $12,055.14 |
DisclosureSEC source: 0001628280-17-011677 · wf-form4_151095513198824.xml · nonDerivative · entry 2 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,941 Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 21:45 UTC | HUBBELL INC HUBB · Entity 3208 | SaleCommon Stock | 100 | $120.56 | $12,056.00 |
DisclosureSEC source: 0001628280-17-011677 · wf-form4_151095513198824.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,041 Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 21:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,657.849 | $68.99 Strike: $0.00 | $114,375.00 |
DisclosureSEC source: 0001127602-17-031730 · form4.xml · derivative · entry 2 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,420.0847 Underlying: Common Stock · 1,657.849 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| August 16, 2017 Filed Aug 18, 2017 20:10 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 2,500 | $79.62 | $199,050.00 |
DisclosureSEC source: 0001127602-17-026036 · form4.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,258 F1 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $79.54 and $79.66 per share. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 11:16 UTC | KAMAN Corp KAMN · Entity 91838 | SaleKaman Common Stock | 2,404 | $50.70 | $121,893.38 |
DisclosureSEC source: 0001127602-17-025447 · form4.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,937 F1 · price: This figure represents the weighted average sale price for the shares sold. The range of prices was $50.63 to $50.755. The reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer, or any security holder of the issuer. Read SEC document |
| August 07, 2017 Filed Aug 9, 2017 20:04 UTC | Trane Technologies plc IR · Entity 2921 | SaleOrdinary Shares | 2,500 | $88.03 | $220,076.25 |
DisclosureSEC source: 0001466258-17-000213 · wf-form4_150230904650474.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,931.58 F1 · price: This transaction was executed in multiple trades ranging from $88.0300 to $88.0350 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| June 08, 2017 Filed Jun 9, 2017 20:07 UTC | Trane Technologies plc IR · Entity 2921 | GrantOrdinary Shares | 1,620 | $0.00 | $0.00 |
DisclosureSEC source: 0001466258-17-000196 · wf-form4_149703885810374.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,158.76 F1 · shares: Represents restricted stock units that fully vest on June 8, 2018. Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 20:14 UTC | Trane Technologies plc IR · Entity 2921 | Tax withholdingOrdinary Shares | 1,032 | $89.64 | $92,503.32 |
DisclosureSEC source: 0001466258-17-000175 · wf-form4_149678008379138.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,538.76 Read SEC document |
| May 10, 2017 Filed May 12, 2017 21:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,413.0838 | $80.94 Strike: $0.00 | $114,375.00 |
DisclosureSEC source: 0001127602-17-017952 · form4.xml · derivative · entry 2 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,012.5537 Underlying: Common Stock · 1,413.0838 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 02, 2017 Filed May 4, 2017 21:47 UTC | HUBBELL INC HUBB · Entity 3208 | GrantCommon Stock | 1,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-17-004977 · wf-form4_149393446196873.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,141 F1 · price: Restricted stock grant vesting on date of next regularly scheduled Annual Meeting of Shareholders to be held in 2018. Read SEC document |
| May 01, 2017 Filed May 3, 2017 20:43 UTC | PUBLIC SERVICE ENTERPRISE GROUP INC PEG · Entity 203 | GrantRestricted Stock Units · Derivative | 3,089 | $43.71 | $135,020.19 |
DisclosureSEC source: 0001225208-17-009059 · doc4.xml · derivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,441.9061 Underlying: Common Stock · 3,089 shares Expires not disclosed F1 · derivative.exercise_price: Restricted Stock Units convert to common stock on a one-for-one basis. Restricted Stock Units represent the share equivalent of amount granted, with payment deferred, under the Equity Compensation Plan For Directors. F2 · kind: Restricted Stock Units are subject to forfeiture if a director leaves service and are paid in shares of common stock after termination of service. F3 · derivative.exercise_date: The derivative, Restricted Stock Units, do not have a corresponding exercisable date nor expiration date. F3 · derivative.expiration_date: The derivative, Restricted Stock Units, do not have a corresponding exercisable date nor expiration date. F4 · balance_after: Includes accrued dividend equivalent unit reinvestment, including amounts previously accrued but not reflected in the total shown in previous filings. Also includes corrected amount to reflect previously reported amounts inadvertently omitted from total shown in previous filings. Does not include previously reported phantom stock (deferred under the Deferred Compensation Plan For Directors) inadvertently included in total shown in previous filings. Read SEC document |
| April 19, 2017 Filed Apr 20, 2017 15:53 UTC | KAMAN Corp KAMN · Entity 91838 | GrantKaman Common Stock | 2,697 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-015177 · form4.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,341 F1 · shares: Represents an unrestricted equity award under the Corporation's 16b-3 qualified 2013 Management Incentive Plan. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 625.3722 | $83.95 Strike: $0.00 | $52,500.00 |
DisclosureSEC source: 0001127602-16-066166 · form4.xml · derivative · entry 2 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,044.2443 Underlying: Common Stock · 625.3722 shares Expires not disclosed F2 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F3 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F3 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 02, 2016 Filed Nov 4, 2016 20:20 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 737 | $83.95 | $61,871.15 |
DisclosureSEC source: 0001127602-16-066166 · form4.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,758 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| September 06, 2016 Filed Sep 8, 2016 20:04 UTC | Trane Technologies plc IR · Entity 2921 | SaleOrdinary Shares | 2,100 | $67.99 | $142,783.20 |
DisclosureSEC source: 0001466258-16-000512 · wf-form4_147336508463070.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,647.54 Read SEC document |
| May 19, 2016 Filed May 20, 2016 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 520.0594 | $100.95 Strike: $0.00 | $52,500.00 |
DisclosureSEC source: 0001127602-16-052950 · form4.xml · derivative · entry 2 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,788.8582 Underlying: Common Stock · 520.0594 shares Expires not disclosed F2 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F3 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F3 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 19, 2016 Filed May 20, 2016 20:53 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 612 | $100.95 | $61,781.40 |
DisclosureSEC source: 0001127602-16-052950 · form4.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,021 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| November 04, 2015 Filed Nov 6, 2015 21:10 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,148.6894 | $99.57 Strike: $0.00 | $114,375.00 |
DisclosureSEC source: 0001127602-15-030631 · form4.xml · derivative · entry 2 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,827.3877 Underlying: Common Stock · 1,148.6894 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 07, 2015 Filed May 11, 2015 20:10 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,151.1171 | $99.36 Strike: $0.00 | $114,375.00 |
DisclosureSEC source: 0001127602-15-016840 · form4.xml · derivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,352.9756 Underlying: Common Stock · 1,151.1171 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 05, 2014 Filed Nov 6, 2014 22:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,307.1429 | $87.50 Strike: $0.00 | $114,375.00 |
DisclosureSEC source: 0001127602-14-031478 · form4.xml · derivative · entry 2 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,864.9766 Underlying: Common Stock · 1,307.1429 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 08, 2014 Filed May 9, 2014 20:17 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,507.7116 | $75.86 Strike: $0.00 | $114,375.00 |
DisclosureSEC source: 0001127602-14-016997 · form4.xml · derivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,243.3818 Underlying: Common Stock · 1,507.7116 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 06, 2013 Filed Nov 8, 2013 21:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,673.3208 | $63.87 Strike: $0.00 | $106,875.00 |
DisclosureSEC source: 0001127602-13-031074 · form4.xml · derivative · entry 2 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,384.2013 Underlying: Common Stock · 1,673.3208 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 09, 2013 Filed May 10, 2013 20:22 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 1,859.019 | $57.49 Strike: $0.00 | $106,875.00 |
DisclosureSEC source: 0001127602-13-016464 · form4.xml · derivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,248.6363 Underlying: Common Stock · 1,859.019 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 08, 2012 Filed Nov 9, 2012 21:03 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 2,261.4689 | $46.43 Strike: $0.00 | $105,000.00 |
DisclosureSEC source: 0001127602-12-030326 · form4.xml · derivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,212.2105 Underlying: Common Stock · 2,261.4689 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| May 10, 2012 Filed May 14, 2012 20:06 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 2,284.0983 | $45.97 Strike: $0.00 | $105,000.00 |
DisclosureSEC source: 0001127602-12-016750 · form4.xml · derivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,557.6858 Underlying: Common Stock · 2,284.0983 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 02, 2011 Filed Nov 4, 2011 20:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 2,725.7478 | $35.77 Strike: $0.00 | $97,500.00 |
DisclosureSEC source: 0001127602-11-028660 · form4.xml · derivative · entry 2 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,025.8404 Underlying: Common Stock · 2,725.7478 shares Expires not disclosed F2 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F3 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. F3 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 02, 2011 Filed Nov 4, 2011 20:07 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 209 | $35.77 | $7,475.93 |
DisclosureSEC source: 0001127602-11-028660 · form4.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,409 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 11, 2011 Filed May 13, 2011 20:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantShare Credits · Derivative | 2,600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-016270 · form4.xml · derivative · entry 2 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,088.4399 Underlying: Common Stock · 2,600 shares Expires not disclosed F2 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F3 · derivative.exercise_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. F3 · derivative.expiration_date: Consists of Deferred Stock Compensation payable pursuant to Insider's election. Read SEC document |
| May 11, 2011 Filed May 13, 2011 20:14 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 200 | $37.50 | $7,500.00 |
DisclosureSEC source: 0001127602-11-016270 · form4.xml · nonDerivative · entry 1 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,200 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.